# Atomized Intranasal Vs Intravenous Ketorolac in Acute Renal Colic Pain Management.

> **NCT04441762** · PHASE2,PHASE3 · COMPLETED · sponsor: **Oman Medical Speciality Board** · enrollment: 171 (actual)

## Conditions studied

- Acute Renal Colic

## Interventions

- **DRUG:** Intravenous Ketorolac Tromethamine
- **DRUG:** Intranasal Ketorolac Tromethamine

## Key facts

- **NCT ID:** NCT04441762
- **Lead sponsor:** Oman Medical Speciality Board
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-30
- **Primary completion:** 2022-02-01
- **Final completion:** 2022-02-01
- **Target enrollment:** 171 (ACTUAL)
- **Last updated:** 2022-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04441762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04441762, "Atomized Intranasal Vs Intravenous Ketorolac in Acute Renal Colic Pain Management.". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT04441762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*